Abstract

Cell-based regeneration of damaged or diseased articular cartilage still faces significant clinical challenge due to inadequate environmental regulation of stem cell proliferation and chondrogenic differentiation. The role of insulin-like growth factor in critical steps of human bone marrow-derived mesenchymal stem cell chondrogenesis has potential in optimizing the therapeutic use of mesenchymal stem cells in cartilage disorders. In addition to the previously described benefits of recombinant adeno-associated viral vector for in vivo gene therapy, demonstrated by Frisch and colleagues, such vector is also a safe and efficient delivery system for the genetic modification of human bone marrow-derived mesenchymal stem cells via ex vivo insulin-like growth factor 1 gene transfer, so that implanted mesenchymal stem cells continuously release a therapeutic level of insulin-like growth factor 1 to achieve sustained mesenchymal stem cell chondrogenesis for cartilage regeneration.

Highlights

  • No effective treatment for articular cartilage injuries and disorders has been developed to rescue the impaired cartilage or prevent damage progression or both

  • There is a critical need for the development of a safe and effective delivery system to stably deliver insulin-like growth factor 1 (IGF-1) to achieve a sustained, long-term effect on chondrogenesis of Human mesenchymal stem cell (hMSC)

  • In a recent issue of Stem Cell Research & Therapy, Frisch and colleagues [1] demonstrate that the ex vivo gene transfer of IGF-1 to stem cells through a recombinant adeno-associated viral vector system, prior to their seeding onto biomaterial or implantation or both, is effective for sustained production of IGF-1

Read more

Summary

Introduction

No effective treatment for articular cartilage injuries and disorders has been developed to rescue the impaired cartilage or prevent damage progression or both. Stem cell-based tissue engineering for cartilage regeneration is a promising alternative pathway in the regeneration of damaged or diseased articular cartilage tissues or both; it needs to be optimized to enhance cell proliferation and chondrogenic

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.